CIK 0002036042 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Sionna Therapeutics, Inc.
Sign in to watch- Ticker
- SION
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-819-2020
- Business address
- 21 HICKORY DRIVE, SUITE 500, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $21,835,018
- in 1 filing
Net −$21,835,018. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-06 | Viney Joanne L. Director | Grant or award · Stock Option (Right to Buy) | +39,919 | 39,919 | ||
| 2025-02-06 | Cloonan Michael President & CEO | Grant or award · Stock Option (Right to Buy) | +450,252 | 450,252 | ||
| 2025-02-06 | Ridloff Elena CFO & Head of Corp. Dev. | Grant or award · Stock Option (Right to Buy) | +157,820 | 157,820 | ||
| 2025-02-06 | McKee Charlotte Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +148,536 | 148,536 |
Page 15 of 15 · 284 trades